Demis Hassabis

In what can be called a major breakthrough for synthetic biology and AI-powered biosecurity, Google DeepMind, Google’s AI lab, has developed a new method to watermark AI-designed proteins, establishing a permanent proof of origin directly inside biological code. Published in the journal Nature, the proof-of-concept technology, which is named SynthID Bio, solves a long-standing technical challenge: embedding an non-no

View original ↗

Listen: Solving all disease is one of the most monumentally complex challenges in science. Today, for the first time, AI provides the foundation to make it achievable. Tackling the frontier of human health is our mission, and it means identifying exactly where modern AI can make the greatest difference. We see drug discovery as the critical wedge in solving all disease, and therefore our initial focal point where AI

View original ↗

Demis Hassabis, CEO of Google DeepMind and 2024 Nobel laureate in Chemistry, has spent the first months of 2026 articulating a specific and measurable thesis: AlphaFold, the protein-structure model that now serves more than three million researchers across 190 countries, is the first rung in an AI-powered scientific revolution, not the last. His clearest statement of this position came in a Semafor interview publishe

View original ↗

Demis Hassabis traces how AlphaGo's search and learning ideas fed into AlphaFold, AlphaProof, AlphaEvolve and the broader scientific-AI program.

View original ↗

Hassabis explains why DeepMind combines scaling with algorithmic innovation and treats advanced AI as both a scientific instrument and a model of intelligence.

View original ↗